Cassava Sciences Inc

Finanzen von Cassava Sciences Inc (SAVA)

$2.380

+0.292 (+12.26%)Zum Schluss

Profitabilität und Margen von SAVA

Evaluating the bottom line, Cassava Sciences Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -82.66%, provide a clear picture of how effectively SAVA converts its operational activities into shareholder value.

SAVA im Vergleich zur Peergroup

In the context of the broader market, SAVA competes directly with industry leaders such as COYA and SEER. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, SAVA's gross margin of N/A stands against COYA's 100.00% and SEER's 98.71%. Such benchmarking helps identify whether Cassava Sciences Inc is trading at a premium or discount relative to its financial performance.

Finanzielle Entwicklung von Cassava Sciences Inc

The company's financial performance in Q3 2025 is weak. Revenue remains at 0, with no growth YoY. Net income dropped significantly by -61.32% YoY to -$10.8 million, and EPS declined by -62.07% YoY to -0.22. Gross margin remains at 0, indicating no profitability.

Financials

FY2025Q4
YoY:
-54.04%
-13.55M
Operating Profit
FY2025Q4
YoY:
-54.56%
-12.54M
Net Income after Tax
FY2025Q4
YoY:
-54.39%
-0.26
EPS - Diluted
FY2025Q4
YoY:
-83.29%
-10.25M
Free Cash Flow

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten